Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC
KYTX — Kyverna Therapeutics, Inc.
N/A · Quality 7/100
Value Score 30 days ago: 9.5 → today 13.8
Price
5.12
Intrinsic value
-
no positive per-share earnings - the P/E-blend method needs a profit to value
Margin of safety
-
Implied growth (reverse DCF)
-
a described calculation from stated inputs, not a forecast
Value Score
13.8
Quality
7
Psychology
42.8
Discovery
6.4
price/volume attention only
Moat score
16.7
erosion: none
Value Score: bottom 24% of Russell 3000 · Quality: bottom 7%
Open the interactive Deep Dive for KYTX →
Use this data programmatically
This page's numbers are also available as JSON at /api/v1/deep-dive/KYTX - see the API docs for the full read-only surface, including an MCP server for AI assistants.
Common questions
What is Kyverna Therapeutics, Inc.'s Value Score?
Kyverna Therapeutics, Inc.'s Value Score is 13.8 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number. This is a described calculation from public data, not a recommendation.